Tuesday, April 03, 2018



BOSTON — April 3, 2018— Partners HealthCare, the nation’s largest academic research enterprise, today announced the fourth annual World Medical Innovation Forum, which will bring more than 1,500 health care and technology leaders together in Boston from April 23 to April 25, 2018 to discuss the expanding role of Artificial Intelligence (AI) in health care.

The event will examine how cognitive computing, machine learning and big data are having a transformative impact on medicine.  It is open to investors, entrepreneurs, corporate executives, clinicians, academic researchers, app developers, data scientists, health care policymakers and information technology leaders.
Keynote “Fireside Chats” will be delivered by NVIDIA CEO Jensen Huang, Nuance CEO Paul Ricci, Novartis CEO Vasant Narasimhan, IBM Senior Vice President for Cognitive Solutions and Research John Kelly, U.S. Centers for Medicare and Medicaid Services Administrator Seema Verma, and surgeon, professor and author Atul Gawande.  Other C-level speakers and panelists will include Massachusetts Governor Charlie Baker and executives from Google, Microsoft, Dell EMC, Persistent Systems, GE, Philips, Siemens Healthineers, Boston Scientific, Bayer, Bristol-Myers Squib, Vertex, Pfizer, GSK, Johnson & Johnson, Lilly, Novartis, Amgen, Humana, Wolters Kluwer Health, Cisco, the U.S. Food and Drug Administration, and Blue Cross Blue Shield.  In all, the Forum will feature more than 140 speakers, including leaders from health care, technology and life sciences, top investors, and dozens of Harvard Medical School faculty.
The Forum is chaired by Anne Klibanski, MD, Chief Academic Officer, and Gregg Meyer, MD, Chief Clinical Officer, both of Partners HealthCare.

“In an industry driven by data and analysis, AI is a game changer,” said Meyer.  “AI methodologies, such as those relating to deep neural networks modeled after the human brain, target historic health care challenges, including quality, access and cost. The Forum will help advance this evolution in health care technology.”

Over three days, the Forum will examine AI as it relates to such diverse issues as drug and medical device development, data security, health care costs, workforce development, investment opportunities, and its impact in specific medical disciplines such as radiology, pathology, ophthalmology, anesthesia, and neuropsychology.
“From R&D to care delivery to patient engagement to population health management, AI can improve care while driving innovation and economic growth,” said Klibanski.  “The Forum will illuminate transformational opportunities in health care while addressing the complex societal raised by AI.  As always, our goal at Partners HealthCare is finding ways to improve care for our patients.”

Features of the Forum will include a “First Look” at AI breakthroughs and solutions of the future being developed by early career Harvard researchers, and “Discovery Cafe” workshops hosted by senior Harvard faculty. Topics addressed during the Forum will include Anesthesiology, Clinician Empowerment, Clinical trials, Cost and Access, Data Engineering, Data Security, Drug Development, Drug Discovery, Electronic Health Records, Gene Sequencing, Hospital Management, Medical Devices, Neuroscience, Ophthalmology, Pathology, Radiology, Reimbursement, Research, Venture Investing, and Workforce Development.

The World Medical Innovation Forum is organized by Partners HealthCare Innovation, a division of Partners HealthCare dedicated to advancing the worldwide commercial application of the unique capabilities of Partners’ Harvard faculty.  
Sponsors of the Forum include GE, Nuance, Nvidia, Bayer, Bristol-Myers Squibb, Cisco, Dell Technologies, Siemens Healthineers, Wolters Kluwer Health, Amgen, Boston Scientific, MGH & BWH Center for Clinical Data Science, Mintz Levin, Northern Light Venture Capital, Persistent Systems, Philips, Pure Storage, and Vertex.

No comments:

Post a Comment